Clinical Trial Update: Oxaliplatin Adjuvant Chemotherapy After Curative Resection of Primary Colon Cancer

View source ↗

Summary

An ongoing clinical trial evaluating oxaliplatin as adjuvant chemotherapy after curative resection for colon cancer is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer

Drugs mentioned

• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Boryung Pharmaceutical Co., Ltd | Conditions: Stage II Colon Cancer, Stage III Colon Cancer | Status: ACTIVE_NOT_RECRUITING